Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Elsevier Business Intelligence

01:04 EDT 21st October 2017 | BioPortfolio

Here are the most relevant search results for "Elsevier Business Intelligence" found in our extensive news archives from over 250 global news sources.

More Information about Elsevier Business Intelligence on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Elsevier Business Intelligence for you to read. Along with our medical data and news we also list Elsevier Business Intelligence Clinical Trials, which are updated daily. BioPortfolio also has a large database of Elsevier Business Intelligence Companies for you to search.

Showing News Articles 1–25 of 2,200+ from Elsevier Business Intelligence

Friday 20th October 2017

Manufacturing Compliance Updates In Brief: Dasan, Akorn, Evertogen And 10 Others

Dasan didn't test glycerin for DEG; Akorn didn't see the problem with washed-vial conveyor belt crumbs; Evertogen was...

Rx Drug Ads: Number Of Side Effects, Price-Comparison Claims Impact Risk Perception

Commercials citing non-severe side effects dilute message, London study concludes; US FDA finds price comparison claims may c...

How to Avoid Data Integrity Disasters In Your Manufacturing Network

Pharmaceutical manufacturers can establish a competitive advantage by preventing questions about the integrity of their produ...

Third Time Lucky For Disabling Skin Disease Biological As EMA Says Yes For PRIME

A biological that is being developed to treat the life-threatening genetic disorder, XLHED, in babies has had its ups and...&...

England’s NICE Takes Tough Stance On Opdivo; No Relief from Cancer Drugs Fund

HTA body NICE has rejected in draft guidance the use in the NHS in England of Opdivo (nivolumab) in bladder...  ...

Thursday 19th October 2017

Seattle Genetics and Merck in trial collaboration for triple-negative breast cancer

Seattle Genetics Inc. signed another trial collaboration for its antibody-drug conjugate candidate SGNLIV1A, this time with M...

Genentech and Seattle Genetics study ADC/PD-L1 combo for breast cancer

Genentech Inc. and Seattle Genetics Inc. entered a trial collaboration in which they will evaluate the combination of Seattle...

Aries and Olympus to co-promote Eleview endoscopy product in US

Olympus Medical America Inc. will co-promote in the US the Eleview endoscopy product with Aries Pharmaceuticals Inc., the US ...

Akcea gets $50mm from Novartis in private placement concurrent with IPO

Concurrent with its IPO, cardiometabolic disease-focused Akcea Therapeutics Inc. issued 6.25mm shares of its common stock (at...

Ampio Pharmaceuticals nets $6.4mm in RDO

Ampio Pharmaceuticals Inc. (inflammatory-focused therapeutics) netted $6.4mm in a registered direct offering of 7.7mm common ...

Roche forms antibiotics collaboration with Warp Drive Bio

Roche received options to license exclusive worldwide development and commercialization rights to certain classes of Warp Dri...

Private placement nets $15.5mm for ArQule

ArQule Inc. (cancer and rare disease drug development) netted $15.5mm through a private placement of 13.9mm common shares at ...

Restoration Robotics nets $23.3mm in IPO

Restoration Robotics Inc. (robotic hair transplant system) netted $23.3mm in its initial public offering on Nasdaq of 3.6mm s...

New ICH Guide To Eliminate ‘Discordant Advice’ On Juvenile Animal Studies

Experts at the International Council for Harmonisation have nearly completed the first draft of a guideline that explains in ...

Wednesday 18th October 2017

Public offering nets $86.5mm for Abeona

Abeona Therapeutics Inc. (developing gene therapies for rare genetic diseases) publicly sold 5.75mm common shares (including ...

CASI nets $23.6mm through registered direct offering

CASI Pharmaceuticals Inc. netted $23.6mm through a registered direct offering of 7.95mm common shares at $3 (a 38% premium) t...

BioTime nets $27mm in FOPO

BioTime Inc. (products for degenerative diseases) netted $27mm in a follow-on equity offering of 11mm common shares (includin...

Tandem Diabetes Care nets $15.15mm via follow-on

Tandem Diabetes Care Inc. (developer of the t:slim X2 insulin pump) netted $15.15mm through the follow-on public offering of ...

Lilly and CureVac pen $1.8bn immuno-oncology deal

Eli Lilly & Co. and CureVac AG partnered to discover and develop up to five cancer vaccines in a deal that could be worth a m...

Protagonist Therapeutics nets $56.4mm via FOPO

GI-focused Protagonist Therapeutics Inc. (peptide therapies) netted $56.4mm via a follow-on public offering of 3.53mm common ...

Gemini Therapeutics raises $2mm in seed round

Gemini Therapeutics Inc. (gene therapy for rare and ophthalmic diseases) raised $2mm in its seed financing round with OrbiMed...

RDO nets $7.5mm for Rexahn

Rexahn Pharmaceuticals Inc. (oncology) netted $7.5mm through a registered direct offering of 3.6mm common shares at $2.45 (an...

Gemini Therapeutics raises $42.5mm in Series A financing

Gemini Therapeutics Inc. (precision medicine for rare genetic diseases and ophthalmology) raised $42.5mm in its Series A fina...

Public offering nets $75.2mm for Abeona

Abeona Therapeutics Inc. (developing gene therapies for rare genetic diseases) publicly sold 5mm common shares at $16 for net...

Consultation To Help Determine Whether EU SPC Framework Fit For Purpose

The European Commission has launched a consultation on proposals to “recalibrate” supplementary protection certificates a...


Quick Search
Advertisement
 

News Quicklinks